>Axilyta 5 : Axitinib 5mg Tablets<

Axilyta 5 Axitinib 5mg Tablet Description:

Axilyta 5 – Axitinib 5mg Tablet is a targeted therapy used primarily in the treatment of advanced renal cell carcinoma (RCC) (kidney cancer). It is a potent, selective inhibitor of vascular endothelial growth factor (VEGF) receptors 1, 2, and 3, which play a critical role in tumor angiogenesis. By blocking these receptors, Axilyta 5 – Axitinib 5mg helps to reduce the blood supply to tumors, potentially slowing their growth and spread.

Axilyta 5 – Axitinib 5mg is typically administered to patients who have not responded to prior therapies or as a second-line treatment following other medications. The effectiveness of Axitinib has been noted in various clinical trials, demonstrating improved progression-free survival rates compared to alternative treatments.

Uses:

Axilyta 5 – Axitinib 5mg is primarily used for the treatment of advanced renal cell carcinoma (kidney cancer) in patients who have previously received other cancer therapies. It works as a targeted therapy, inhibiting the growth of cancer cells by blocking specific proteins involved in tumor growth and progression.